Related Experiment Video

Updated: Aug 15, 2026

Expansion of Human Peripheral Blood γδ T Cells using Zoledronate
13:08

Expansion of Human Peripheral Blood γδ T Cells using Zoledronate

Published on: September 9, 2011

Expression of common gamma chain on peripheral blood mononuclear cells in Crohn's disease

I Kirman1, O H Nielsen

  • 1Department of Medical Gastroenterology C, Herlev Hospital, University of Copenhagen, Denmark.

Digestive Diseases and Sciences
|February 1, 1997
PubMed

Insights

In active Crohn's disease (CD), common gamma chain (gamma c) expression on immune cells is reduced, potentially impacting IL-4 function and contributing to this inflammatory bowel disease.

Area of Science:

  • Immunology
  • Gastroenterology
  • Cell Biology

Background:

  • Immune cell responses to cytokines like IL-2 and IL-4 are impaired in inflammatory bowel disease (IBD).
  • The common gamma chain (gamma c) is a crucial component of receptors for several important cytokines, including IL-2 and IL-4.

Purpose of the Study:

  • To investigate whether altered expression of the common gamma chain (gamma c) contributes to immune dysfunction in IBD.
  • To assess the relationship between gamma c expression and IL-4 binding on peripheral blood mononuclear cells (PBMCs) in Crohn's disease (CD).

Main Methods:

  • Flow cytometry was used to analyze gamma c expression on PBMCs from active CD patients, inactive CD patients, and healthy controls.
  • Biotinylated IL-4 and two-color flow cytometry were employed to assess IL-4 binding in conjunction with gamma c expression.
  • In vitro cell activation models were used to explore the impact of cell activation on gamma c expression.

Main Results:

  • Mean fluorescence intensity of gamma c expression was significantly lower in active CD patients compared to inactive CD patients and healthy controls.
  • Down-regulation of gamma c expression was associated with a decrease in the number of IL-4 binding cells.
  • In vitro studies confirmed that cell activation could lead to gamma c down-regulation and reduced IL-4 binding.

Conclusions:

  • Reduced expression of gamma c on PBMCs in active CD patients may play a significant role in the pathogenesis of this chronic intestinal disorder.
  • The observed decrease in gamma c expression and IL-4 binding suggests a potential mechanism for immune dysregulation in active CD.

More Related Videos

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

T and B Cell Receptor Immune Repertoire Analysis using Next-generation Sequencing08:59

T and B Cell Receptor Immune Repertoire Analysis using Next-generation Sequencing

Published on: January 12, 2021

Related Concept Videos

B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...